A pilot trial of personalized neoantigen pulsed autologous dendritic cell vaccine as adjuvant treatment in hepatocellular carcinoma

被引：0
|
作者：
Wu, Qiuji
Li, Qiu
Yang, Li
Xu, Heng
机构：
[1] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu, Sichuan, Peoples R China
[2] Sichuan Univ, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China
[3] Sichuan Univ, West China Hosp, Chengdu, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14658
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A pilot trial of personalized neoantigen pulsed autologous dendritic cell vaccine as adjuvant treatment in hepatocellular carcinoma
    Wu, Qiuji
    Li, Qiu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Personalized neoantigen-pulsed autologous dendritic cells vaccine as an adjuvant treatment for patients with newly-diagnosed glioblastoma multiforme: A phase I trial
    Zhang, Yang
    Chi, Xiaohan
    Cheng, Xudong
    Zhang, Yu
    Zhang, Kangna
    Huang, Na
    Ji, Nan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer
    Zhenyu Ding
    Qing Li
    Rui Zhang
    Li Xie
    Yang Shu
    Song Gao
    Peipei Wang
    Xiaoqing Su
    Yun Qin
    Yuelan Wang
    Juemin Fang
    Zhongzheng Zhu
    Xuyang Xia
    Guochao Wei
    Hui Wang
    Hong Qian
    Xianling Guo
    Zhibo Gao
    Yu Wang
    Yuquan Wei
    Qing Xu
    Heng Xu
    Li Yang
    Signal Transduction and Targeted Therapy, 6
  • [4] Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer
    Ding, Zhenyu
    Li, Qing
    Zhang, Rui
    Xie, Li
    Shu, Yang
    Gao, Song
    Wang, Peipei
    Su, Xiaoqing
    Qin, Yun
    Wang, Yuelan
    Fang, Juemin
    Zhu, Zhongzheng
    Xia, Xuyang
    Wei, Guochao
    Wang, Hui
    Qian, Hong
    Guo, Xianling
    Gao, Zhibo
    Wang, Yu
    Wei, Yuquan
    Xu, Qing
    Xu, Heng
    Yang, Li
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [5] Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial
    Yarchoan, Mark
    Gane, Edward J.
    Marron, Thomas U.
    Perales-Linares, Renzo
    Yan, Jian
    Cooch, Neil
    Shu, Daniel H.
    Fertig, Elana J.
    Kagohara, Luciane T.
    Bartha, Gabor
    Northcott, Josette
    Lyle, John
    Rochestie, Sarah
    Peters, Joann
    Connor, Jason T.
    Jaffee, Elizabeth M.
    Csiki, Ildiko
    Weiner, David B.
    Perales-Puchalt, Alfredo
    Sardesai, Niranjan Y.
    NATURE MEDICINE, 2024, 30 (03) : 1044 - 1053
  • [6] Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
    Zhang, Rui
    Yuan, Fengjiao
    Shu, Yang
    Tian, Yaomei
    Zhou, Bailing
    Yi, Linglu
    Zhang, Xueyan
    Ding, Zhenyu
    Xu, Heng
    Yang, Li
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (01) : 135 - 145
  • [7] Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
    Rui Zhang
    Fengjiao Yuan
    Yang Shu
    Yaomei Tian
    Bailing Zhou
    Linglu Yi
    Xueyan Zhang
    Zhenyu Ding
    Heng Xu
    Li Yang
    Cancer Immunology, Immunotherapy, 2020, 69 : 135 - 145
  • [8] Spleen-targeted neoantigen DNA vaccine for personalized immunotherapy of hepatocellular carcinoma
    Wu, Ming
    Luo, Zijin
    Cai, Zhixiong
    Mao, Qianqian
    Li, Zhenli
    Li, Hao
    Zhang, Cao
    Zhang, Yuting
    Zhong, Aoxue
    Wu, Liming
    Liu, Xiaolong
    EMBO MOLECULAR MEDICINE, 2023, 15 (10)
  • [9] Autologous dendritic cells pulsed with lysate from an allogeneic hepatic cancer cell line as a treatment for patients with advanced hepatocellular carcinoma: A pilot study
    Ghafar, Muhammad Tarek Abdel
    Morad, Morad Ahmed
    El-Zamarany, Enas A.
    Ziada, Dina
    Soliman, Hanan
    Abd-Elsalam, Sherief
    Salama, Marwa
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 82
  • [10] An adjuvant personalized neoantigen peptide vaccine for the treatment of malignancies (PGV-001).
    Marron, Thomas Urban
    Saxena, Mansi
    Bhardwaj, Nina
    Meseck, Marcia
    Rubinsteyn, Alex
    Finnigan, John
    Kodysh, Julia
    Blazquez, Ana
    O'Donnel, Tim
    Galsky, Mathew
    Doroshow, Deborah
    Miles, Brett
    Misiukiewicz, Krysztof
    Irie, Hanna
    Tiersten, Amy
    Parekh, Samir
    Posner, Marshall
    Wolf, Andrea
    Mandeli, John
    Brody, Rachel
    Gnjatic, Sacha
    Schadt, Eric
    Friedlander, Philip
    Hammerbacher, Jeffrey
    CANCER RESEARCH, 2021, 81 (13)
12345